Companies /Healthcare

OUTLOOK THERAPEUTICS INC

NASDAQ: OTLK Biotechnology
$0.65
▼ $0.03 (−4.17%) today
Markets closed · 5:32am ET
Today · % change

Fundamentals

Market Cap
$158.9M
Revenue (TTM)
$-1,163,481
EPS (TTM)
$-0.69
52-Week Range
$0 – $3
Street Target
$5.03

About Outlook Therapeutics

Outlook Therapeutics, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for various ophthalmic indications. The company is headquartered in Cranbury, New Jersey.

OTLK Coverage